Get the Stockscreener App
0.56
2.27%
-0.013
After Hours:
.56
Xtant Medical Holdings Inc stock is traded at $0.56, with a volume of 15,705.
It is down -2.27% in the last 24 hours and down -21.68% over the past month.
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as could be used in conjunction with a hardware plate system. The company also provides OsteoSTX for posterolateral spine surgery applications, including scoliosis procedures; and 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers various products to treat a range of spinal and sacroiliac conditions, including trauma, degeneration, deformity, and tumor. Xtant Medical Holdings, Inc. markets its products through direct sales, consignment agents, reseller distributors, private label distributors, and technology licensees. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
See More
Previous Close:
$0.573
Open:
$0.54
24h Volume:
15,705
Relative Volume:
0.09
Market Cap:
$78.02M
Revenue:
$78.46M
Net Income/Loss:
$2.75M
P/E Ratio:
56.00
EPS:
0.01
Net Cash Flow:
$-12.42M
1W Performance:
-9.68%
1M Performance:
-21.68%
6M Performance:
-8.93%
1Y Performance:
-18.72%
1-Day Range:
$0.54
$0.5699
1-Week Range:
$0.54
$0.66
52-Week Range:
$0.331
$0.778
Xtant Medical Holdings Inc Stock (XTNT) Company Profile
Name
Xtant Medical Holdings Inc
Sector
Industry
Phone
406-388-0480
Address
664 Cruiser Lane, Belgrade, MT
Compare XTNT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XTNT
Xtant Medical Holdings Inc
|
0.56 | 79.83M | 78.46M | 2.75M | -12.42M | 0.01 |
|
ABT
Abbott Laboratories
|
127.29 | 219.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.41 | 155.22B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
377.79 | 150.09B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.34 | 115.62B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.33 | 46.52B | 5.69B | 4.15B | 623.10M | 6.95 |
Xtant Medical Holdings Inc Stock (XTNT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-05-23 | Initiated | BTIG Research | Buy |
| Nov-15-18 | Reiterated | Maxim Group | Buy |
| Feb-14-18 | Reiterated | Maxim Group | Buy |
Xtant Medical Holdings Inc Stock (XTNT) Latest News
Risk adjusted return profile for Xtant Medical Holdings Inc. analyzedFree Exit Ready Momentum Stock Watchlist - Newser
Does Xtant Medical Holdings Inc. stock pay reliable dividendsEntry Timing with Downside Risk Analysis - Newser
Applying Elliott Wave Theory to Xtant Medical Holdings Inc.Free Day Trading Signals With High Precision - Newser
Is Xtant Medical Holdings Inc. stock ready for a breakoutVolatility Analysis and Entry Risk Mapping - Newser
Is Xtant Medical Holdings Inc. a growth stock or a value stockEarnings Report Recommendation To Watch Now - jammulinksnews.com
New Product Launches: Will They Boost Xtant Medical Holdings Inc. Stock in 2025Weekly Stock Watch With Growth Focus Expanded - metal.it
What makes Xtant Medical Holdings Inc. stock price move sharplyShort Squeeze Opportunities with Indicators - Newser
Backtesting results for Xtant Medical Holdings Inc. trading strategiesDownside Risk Evaluation and Stock Analysis - Newser
Is Xtant Medical Holdings Inc. a candidate for recovery playDaily Stock Watch Summary with Key Insights - Newser
How to integrate Xtant Medical Holdings Inc. into portfolio analysis toolsFree Real Time Trade Opportunity Alerts - Newser
How Xtant Medical Holdings Inc. stock performs during market volatilityHigh Return Idea With Technical Filter - Newser
Why Xtant Medical Holdings Inc. stock attracts strong analyst attentionWeekly Movement Forecast With Chart Signals - Newser
Is Xtant Medical Holdings Inc. stock overhyped or has real potentialInvestment Life Cycle Planning Summary - Newser
What technical models suggest about Xtant Medical Holdings Inc.’s comeback - Newser
Will Xtant Medical Holdings Inc. Stock Benefit from AI and Green Energy TrendsFree Expert Verified Stock Trade Ideas - Newser
Xtant Medical Partners With B2i Digital to Educate Investors on Its Orthobiologics Innovation and Market Opportunity - NewMediaWire
What are Xtant Medical Holdings Inc. company’s key revenue driversMarket Forecast Picks That Work - jammulinksnews.com
How does Xtant Medical Holdings Inc. compare to its industry peersMaximize returns with strategic trading plans - jammulinksnews.com
Should I hold or sell Xtant Medical Holdings Inc. stock in 2025Free Stock Review For Consistent Profits - jammulinksnews.com
Is Xtant Medical Holdings Inc. a candidate for recovery play Trend Reversal Probability Forecast Update - Newser
Does Xtant Medical Holdings Inc. stock perform well during market downturnsUnprecedented growth rates - jammulinksnews.com
What are analysts’ price targets for Xtant Medical Holdings Inc. in the next 12 monthsExplosive wealth accumulation - jammulinksnews.com
Published on: 2025-07-28 04:24:26 - jammulinksnews.com
What institutional investors are buying Xtant Medical Holdings Inc. stockHigh-profit capital plays - jammulinksnews.com
Published on: 2025-07-27 21:37:31 - jammulinksnews.com
Is Xtant Medical Holdings Inc. a Top Dividend Stock to Watch in 2025Breakout Momentum Stocks - Newser
Is Xtant Medical Holdings Inc. a good long term investmentRapidly growing investment returns - PrintWeekIndia
What analysts say about Xtant Medical Holdings Inc. stockHigh-velocity gains - PrintWeekIndia
Xtant Medical Holdings Inc. Stock Analysis and ForecastExplosive portfolio gains - PrintWeekIndia
What drives Xtant Medical Holdings Inc. stock priceFree Trend-Following Techniques - PrintWeekIndia
Can Xtant Medical Holdings Inc. stock recover from recent declineFree Capital Growth Strategies - jammulinksnews.com
Xtant Medical Holdings Inc Stock (XTNT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.21%
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):